Herpesvirus Vaccine
Virus expressing HSV-2 glycoproteins protects against HSV-2 challenge
Published in Drug Week, September 10th, 2004
According to published research from the United States, "A recombinant Oka (ROka) varicella-zoster virus (VZV) vaccine was constructed that expresses herpes simplex virus type 2 (HSV-2) glycoproteins B (gB) and D (gD). Guinea pigs received one of four inocula: uninfected cells; recombinant Oka VZV infected cells; recombinant Oka VZV expressing HSV-2 gB/gD (ROka-gB2/gD2) infected cells; or heat-inactivated ROka-gB2/gD2 infected cells. Only animals inoculated with ROka-gB2/gD2 developed high titers of neutralizing antibodies to HSV-2."
"Animals...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-09-10)
More Articles from Drug Week
- Alcoholism
Topiramate a potential new medication for treating alcoholism - Anemia
Aranesp receives positive regulatory opinion for extended dosing in Europe - Antibiotic Resistance
Resistance to third-generation cephalosporins in Enterobacteriaceae increased - Osteoporosis
First patients given AMG 162 in phase III studies for bone loss - Parkinson Disease
FDA clears gene therapy trial for Parkinson disease - AIDS Therapy
Patient enrollment completed in phase I/II trial in AIDS - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
